CD8A and melanoma: DEXs, stimulated using the Toll-like receptor 3 agonist poly (I:C) and loaded with the B16 antigen, proliferated effector CD8+ T cells and recruited NK and NK-T cells to tumors in melanoma-bearing animals49.